Associate
Scientific Directors
Ethan Dmitrovsky, M.D.
Andrew G. Wallace Professor
Pharmacology & Toxicology and of Medicine
Dartmouth Medical School
Dmitrovsky is a physician-scientist and practicing oncologist. He studies vitamin A derivatives (retinoids) in cancer therapy and prevention and conducts bench to bedside translational research.
His team helped establish successful retinoid differentiation therapy for acute promyelocytic leukemia and developed the genetic test used to diagnose this leukemia and monitor treatment response. The team also investigates ways to combat lung cancer, the most common cause of cancer death for men and women. His team has developed a mouse model that recapitulates frequent features of lung cancers in patients. This is a discovery tool for lung cancer biology, therapy and prevention. Dmitrovsky was on the faculty at Memorial Sloan-Kettering Cancer Center for more than a decade before joining Dartmouth as the Andrew G. Wallace Professor and Chair of the Pharmacology department.
He served a term as Acting Dean of the Dartmouth Medical School. Dmitrovsky serves on several editorial boards including Cancer Research, Clinical Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics and the Journal of the National Cancer Institute.
He is an Associate Scientific Director of the Samuel Waxman Cancer Research Foundation and serves on many scientific advisory boards, including the Board of Scientific Counselors of the National Cancer Institute and the Lance Armstrong Foundation. He testified before the President's Cancer Panel about overcoming barriers to translational research.
Dmitrovsky now serves as Chair of the Board of Scientific Counselors of the National Cancer Institute for Clinical Sciences and Epidemiology. He is an American Cancer Society Professor, who conducts bench to bedside cancer research.
Jonathan D. Licht, M.D.
Johanna Dobe Professor & Chief Division of Hematology/Oncology
Associate Director for Clinical Sciences Research
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Licht is the Johanna Dobe Professor of Medicine and Chief of the Division of Hematology/Oncology at the Northwestern University Feinberg School of Medicine. Licht's laboratory studies aberrant gene regulation repression as a cause of hematologic malignancy, including acute promyelocytic leukemia, multiple myeloma and myeloproliferative neoplasms, and developing small molecules and peptides strategies to revert abnormal gene regulation and treat disease.
Licht has held a Leukemia Society Scholar award and Buroughs Wellcome Clinical Scientist Award in Translational Research. He is currently the Principal Investigator of a Leukemia and Lymphoma Society Specialized Center of Research Excellence grant, studying epigenetic mechanisms in hematological malignancy. He is a Senior Editor of Clinical Cancer Research and serves on the editorial board of Oncogene, Cancer Biology and Therapy and Clinical Epigenetics.
Licht was a Counselor of the American Society for Clinical Investigation and is a member of the Association of American Physicians. He is an Associate Scientific Director of the Samuel Waxman Cancer Research Foundation and currently serves on the National Cancer Institute Board of Scientific Counselors.
